Polaryx Therapeutics Inc. Common Stock

PLYX | NASDAQ

$1.75

-$0.11 (-5.91%)

At close: Oct 30, 2026, 4:00 PM ET

$1.76

+$0.01 (+0.57%)

Pre-market: Nov 2, 2026, 9:08 AM ET

TTM Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024
Net Income	-6.85M	-5.47M	-7.98M	-7.21M	-5.78M	-723K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	575K	575K	4.56M	4.65M	4.54M	87K
Other Working Capital	-117K	-295K	-20K	-3K	-100K	-9K
Other Non-Cash Items	270K	437K	57K	n/a	n/a	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	195K	17K	275K	103K	-332K	-224K
Operating Cash Flow	-5.81M	-4.44M	-3.09M	-2.46M	-1.57M	-860K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	9.68M	-156K	-156K	-156K	n/a	n/a
Financial Cash Flow	14.05M	4.22M	4.47M	6.33M	3M	2.75M
Net Cash Flow	8.24M	-224K	1.38M	3.87M	1.43M	1.89M
Free Cash Flow	-5.81M	-4.44M	-3.09M	-2.46M	-1.57M	-860K
Adj. Free Cash Flow	-6.38M	-5.02M	-7.65M	-7.1M	-6.11M	-947K
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-5.81M	-5.15M	-3.95M	n/a	n/a	n/a